People · Operator
Named in public records as an officer, director or promoter · active 2010–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tioga Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $24.3M | $309.7M | 2010 |
Martin M. Muenchbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Martin M. Muenchbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stuart J.M. Collinson | 1 | 4 |
| James M. Niedel | 1 | 2 |
| James Niedel | 1 | 2 |
| David M. Urso | 1 | 2 |
| Gareth M. Hicks | 1 | 1 |
| Allen M. Mangel | 1 | 1 |
| Arno M. Hartmann | 1 | 1 |
| Jason M. Brown | 1 | 1 |
| Martin M. Meunchbach | 1 | 1 |
| Martin Meunchbach | 1 | 1 |
| Arno Hartmann | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.